Sharps Technology (STSS) Competitors $4.83 +0.05 (+1.05%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$4.80 -0.03 (-0.62%) As of 08/1/2025 07:25 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock STSS vs. ALUR, IRIX, NXL, BDMD, RVP, PETV, OSRH, PSTV, NRXS, and IINNShould you be buying Sharps Technology stock or one of its competitors? The main competitors of Sharps Technology include Allurion Technologies (ALUR), IRIDEX (IRIX), Nexalin Technology (NXL), Baird Medical Investment (BDMD), Retractable Technologies (RVP), PetVivo (PETV), OSR (OSRH), Plus Therapeutics (PSTV), NeurAxis (NRXS), and Inspira Technologies OXY B.H.N. (IINN). These companies are all part of the "medical equipment" industry. Sharps Technology vs. Its Competitors Allurion Technologies IRIDEX Nexalin Technology Baird Medical Investment Retractable Technologies PetVivo OSR Plus Therapeutics NeurAxis Inspira Technologies OXY B.H.N. Sharps Technology (NASDAQ:STSS) and Allurion Technologies (NYSE:ALUR) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, risk, dividends, valuation, media sentiment, analyst recommendations, earnings and institutional ownership. Is STSS or ALUR more profitable? Sharps Technology has a net margin of 0.00% compared to Allurion Technologies' net margin of -86.05%. Allurion Technologies' return on equity of 0.00% beat Sharps Technology's return on equity.Company Net Margins Return on Equity Return on Assets Sharps TechnologyN/A -98.77% -53.85% Allurion Technologies -86.05%N/A -41.49% Do insiders and institutionals hold more shares of STSS or ALUR? 17.2% of Sharps Technology shares are held by institutional investors. Comparatively, 21.4% of Allurion Technologies shares are held by institutional investors. 1.5% of Sharps Technology shares are held by insiders. Comparatively, 22.4% of Allurion Technologies shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Which has stronger valuation & earnings, STSS or ALUR? Sharps Technology has higher earnings, but lower revenue than Allurion Technologies. Allurion Technologies is trading at a lower price-to-earnings ratio than Sharps Technology, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSharps TechnologyN/AN/A-$9.30M-$1.88 thousand0.00Allurion Technologies$32.11M0.64-$26.15M-$12.50-0.22 Which has more risk and volatility, STSS or ALUR? Sharps Technology has a beta of 2.15, indicating that its share price is 115% more volatile than the S&P 500. Comparatively, Allurion Technologies has a beta of -0.45, indicating that its share price is 145% less volatile than the S&P 500. Does the media favor STSS or ALUR? In the previous week, Sharps Technology had 1 more articles in the media than Allurion Technologies. MarketBeat recorded 1 mentions for Sharps Technology and 0 mentions for Allurion Technologies. Allurion Technologies' average media sentiment score of 0.00 beat Sharps Technology's score of -0.71 indicating that Allurion Technologies is being referred to more favorably in the news media. Company Overall Sentiment Sharps Technology Negative Allurion Technologies Neutral Do analysts recommend STSS or ALUR? Allurion Technologies has a consensus price target of $22.83, suggesting a potential upside of 727.29%. Given Allurion Technologies' stronger consensus rating and higher probable upside, analysts plainly believe Allurion Technologies is more favorable than Sharps Technology.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sharps Technology 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Allurion Technologies 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.00 SummaryAllurion Technologies beats Sharps Technology on 11 of the 16 factors compared between the two stocks. Get Sharps Technology News Delivered to You Automatically Sign up to receive the latest news and ratings for STSS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding STSS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart STSS vs. The Competition Export to ExcelMetricSharps TechnologyMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$4.89M$10.40B$5.49B$9.52BDividend YieldN/A1.99%4.73%4.09%P/E Ratio0.0018.4228.7823.81Price / SalesN/A29.01372.2066.04Price / CashN/A22.3135.4557.96Price / Book0.043.478.275.54Net Income-$9.30M$234.77M$3.25B$259.28M7 Day Performance-21.08%-4.82%-3.70%-4.64%1 Month Performance-15.26%1.80%4.34%4.41%1 Year PerformanceN/A-12.51%25.90%17.95% Sharps Technology Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)STSSSharps Technology0.8277 of 5 stars$4.83+1.0%N/AN/A$4.89MN/A0.003Positive NewsALURAllurion Technologies2.1567 of 5 stars$3.18-0.5%$22.83+619.2%-87.5%$23.69M$32.11M-0.25501IRIXIRIDEX0.4914 of 5 stars$1.28+1.7%N/A-36.3%$21.15M$48.67M-2.93120Upcoming EarningsGap UpHigh Trading VolumeNXLNexalin Technology2.3657 of 5 stars$1.23+2.1%$5.00+308.2%-13.3%$21.05M$170K-1.483News CoverageGap DownBDMDBaird Medical InvestmentN/A$3.06-1.9%N/AN/A$20.54MN/A0.00N/AGap DownRVPRetractable Technologies2.8529 of 5 stars$0.68+2.0%N/A-33.7%$20.30M$33.75M-1.26240News CoveragePositive NewsGap DownPETVPetVivoN/A$0.83+3.9%N/A+30.2%$20.29M$1.05M-1.8520Gap DownHigh Trading VolumeOSRHOSRN/A$1.05-2.8%N/AN/A$20.24MN/A0.00N/ANews CoveragePSTVPlus Therapeutics2.1993 of 5 stars$0.38+3.4%$10.83+2,721.2%-67.5%$19.58MN/A-0.1320Gap UpNRXSNeurAxis2.6885 of 5 stars$2.68+2.1%$7.00+161.7%-22.4%$19.41M$2.93M-1.4619Upcoming EarningsGap DownIINNInspira Technologies OXY B.H.N.1.6573 of 5 stars$1.30-7.8%$2.00+53.8%+10.8%$17.80MN/A0.0020 Related Companies and Tools Related Companies Allurion Technologies Competitors IRIDEX Competitors Nexalin Technology Competitors Baird Medical Investment Competitors Retractable Technologies Competitors PetVivo Competitors OSR Competitors Plus Therapeutics Competitors NeurAxis Competitors Inspira Technologies OXY B.H.N. Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:STSS) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredToo busy to trade? Good.Too busy to trade? That might be your edge. This after-hours strategy is built for people who don’t sit at ...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sharps Technology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sharps Technology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free STSS Stock Alerts